Pfizer Ends Development of Obesity Pill Danuglipron After Liver Injury Incident
In a major setback for its ambitions in the booming weight-loss drug market, Pfizer Inc. has officially halted the development…
Category: Research Insights
Deadly Delicious: How Ultra-Processed Food Is Silently Killing Us
In a world where time is short and convenience is king, ultra-processed foods (UPFs) have taken center stage in modern…
Why Is Obesity So High in Samoa? The Hidden Crisis Fueled by Food, Culture—and Politics
Samoa is a land of lush landscapes, vibrant traditions, and resilient people. But it also finds itself on the frontlines…
The Treat and Reduce Obesity Act: Can It Reshape America’s Health Future?
Obesity affects over 100 million Americans, costs the healthcare system hundreds of billions annually, and leads to severe health complications.…
Intermittent Fasting vs. Low-Carb: Science Backs a Simpler Way to Lose Weight
When it comes to weight loss and better health, intermittent fasting (IF) has long been the gold standard. But what…
Indian Pot Belly – A Symbol of Pride or a Health Time Bomb?
Once affectionately dubbed the “badge of prosperity”, the Indian pot belly has been a staple in our collective imagination —…
The Obesity Treatment Market Heats Up: Growth Drivers and Future Implications
The global obesity treatment market is experiencing significant growth and transformation, driven by an increasing prevalence of obesity and a…